Literature DB >> 8072075

Intracavernous injection of prostaglandin E1 plus procaine in the treatment of erectile dysfunction.

P Schramek1, E G Plas, W A Hübner, H Pflüger.   

Abstract

Despite the availability of prostaglandin E1 for more than 7 years as a diagnostic and therapeutic tool in patients with erectile dysfunction, the problem of penile discomfort after prostaglandin E1 application has remained unsolved. In a randomized, double-blind, crossover study we investigated the effect of 2 different prostaglandin E1-procaine concentrations on 24 patients suffering from pain following intracorporeal injection of prostaglandin E1 alone. Intracavernous injection of 20 micrograms. prostaglandin E1 with 10 mg. procaine (study 1) failed to improve local painful sensations. The combination of 20 micrograms. prostaglandin E1 with 20 mg. procaine (study 2) decreased the incidence of local pain significantly (p < 0.01). These preliminary results show that the combination of prostaglandin E1 plus procaine represents a beneficial alternative in patients with penile pain due to the single substance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8072075     DOI: 10.1016/s0022-5347(17)32515-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Comparative tolerability and efficacy of treatments for impotence.

Authors:  W Meinhardt; R F Kropman; P Vermeij
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

Review 2.  Pharmacological management of erectile dysfunction.

Authors:  F Montorsi; G Guazzoni; P Rigatti; G Pozza
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 3.  Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.

Authors:  A P Lea; H M Bryson; J A Balfour
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

4.  Is it worth continuing sexual rehabilitation after radical prostatectomy with intracavernous injection of alprostadil for more than 1 year?

Authors:  René Yiou; Zentia Bütow; Juliette Parisot; Michele Binhas; Odile Lingombet; Deborah Augustin; Alexandre de la Taille; Etienne Audureau
Journal:  Sex Med       Date:  2015-03       Impact factor: 2.491

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.